Synapse - American Society of Hematology

Results (5555)

Functional geriatric assessment tests predict toxicity rates in functional high risk myeloma patients treated with daratumumab, carfilzomib, lenalidomide and dexamethasone in a prospective clinical trial

Meeting Abstract

Shmuel, R.; Tellem, R.; Gatt, M. E.; Lavi, N.; Ganzel, C.; Luttwak, E.; Chubar, E.; Rouvio, O.; Vaxman, I.; Pasvolsky, O.; more...
Blood (2024)

Fulltext@MSK | Save

Comparison of acute kidney injury in patients with relapsed or refractory multiple myeloma following CAR T-cell and bispecific antibody therapies

Meeting Abstract

Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Farzana, T.; Shaikh, A.; Latcha, S.; Gutgarts, V.; Jurgens, E. M.; more...
Blood (2024)

Fulltext@MSK | Save

Body mass index trajectory during triplet induction therapy: Clinical implications in newly diagnosed multiple myeloma

Meeting Abstract

Thirugnanasambandam, R. P.; Firestone, R. S.; Derkach, A.; Furberg, H.; Shekarkhand, T.; Rueda, C.; Maclachlan, K. H.; Hultcrantz, M.; Mailankody, S.; Patel, D.; more...
Blood (2024)

Fulltext@MSK | Save

Trial in progress: An open-label clinical trial of RVU120 as monotherapy and in combination with ruxolitinib in patients with intermediate or high-risk, primary or secondary myelofibrosis (POTAMI-61)

Meeting Abstract

Kuklik, R.; Falkowski, A.; Zaroogian, Z.; Mazan, M.; Szymula, A.; Wilkinson, G.; Adamczyk, E.; Woznicki, J.; Micek, M.; Coelho, D.; more...
Blood (2024)

Fulltext@MSK | Save

Real-word effectiveness of pacritinib in patients with myelofibrosis who have thrombocytopenia and anemia

Meeting Abstract

Rampal, R.; Marrone, M.; Morere, L.; Oladapo, A.; Suthar, P.; Sura, T.; Vasudevan, A.; Vredenburg, M.; Zeng, J.; Mascarenhas, J. O.
Blood (2024)

Fulltext@MSK | Save

Early anemia response in patients with myelofibrosis treated with pacritinib in real-word clinical settings

Meeting Abstract

Mascarenhas, J. O.; Marrone, M.; Morere, L.; Oladapo, A.; Suthar, P.; Sura, T.; Vasudevan, A.; Vredenburg, M.; Zeng, J.; Rampal, R.
Blood (2024)

Fulltext@MSK | Save

High WEE1 expression correlates with poor survival in multiple myeloma, independent of standard prognostic factors

Meeting Abstract

Simhal, A. K.; Firestone, R. S.; Oh, J. H.; Norton, L.; Hultcrantz, M.; Usmani, S. Z.; Maclachlan, K. H.; Deasy, J. O.
Blood (2024)

Fulltext@MSK | Save

Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma

Meeting Abstract

Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
Blood (2024)

Fulltext@MSK | Save

Novel nilotinib tablet formulation: Pharmacokinetic characterization and effects of food

Meeting Abstract

Mauro, M. J.; Radich, J. P.; Jain, P.; Sequeira, D.; Douer, D.
Blood (2024)

Fulltext@MSK | Save

River-52: A multicenter, open-label clinical trial of RVU120 in patients with relapsed or refractory high-risk myelodysplastic syndrome or acute myeloid leukemia

Meeting Abstract

Papayannidis, C.; Madry, K.; Centkowski, P.; Prejzner, W.; Butrym, A.; Chraniuk, D.; Saba, C.; Angelosanto, N.; Curley, R.; Nogai, H.; more...
Blood (2024)

Fulltext@MSK | Save

American Society of Hematology

People

Groups

Results (5555)

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

Meeting Abstract

American Society of Hematology – authorized name for: